Navigation Links
FDA Approves New Arthritis Drug, Bextra

The US Food and Drug Administration has approved a new drug for treating osteoarthritis. Osteoarthritis is a progressive deterioration in the cartilage of certain joints. Unlike rheumatoid arthritis, which is an inherited autoimmune disease, osteoarthritis results from overuse of joints, and can be a byproduct of strenuous sports, obesity or aging.

Pharmacia Corp. makes the drug, Bextra (valdecoxib), while drug giant Pfizer Inc. is helping to promote it. Bextra is a member of a class of anti-inflammatory drugs known as COX-2 inhibitors, which work by blocking// an enzyme called cyclooxygenase 2.

These drugs are believed to sidestep the stomach-irritating effects of other nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin. The drug would also be indicated for treating rheumatoid arthritis and menstrual pain. The exact launch date and price per dose has yet to be determined.


Page: 1

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA Approves New HIV Drug, Viread
3. FDA Approves Birth Control Skin Patch
4. FDA Approves Elidel Cream for Eczema
5. FDA Approves New Anti-Clotting Drug
6. FDA Approves New surgery Treatment for Farsightedness
7. FDA Approves Anti-Cancer Cell Drug - Zevalin
8. FDA Approves Remodulin for Pulmonary Hypertension
Post Your Comments:

Breaking Medicine News(10 mins):
Breaking Medicine Technology: